NO830210L - Tabletter som ikke skader spiseroeret. - Google Patents
Tabletter som ikke skader spiseroeret.Info
- Publication number
- NO830210L NO830210L NO830210A NO830210A NO830210L NO 830210 L NO830210 L NO 830210L NO 830210 A NO830210 A NO 830210A NO 830210 A NO830210 A NO 830210A NO 830210 L NO830210 L NO 830210L
- Authority
- NO
- Norway
- Prior art keywords
- carbonate
- tablets
- tablet
- tablets according
- granulation
- Prior art date
Links
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 18
- 239000003814 drug Substances 0.000 claims description 16
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 14
- 229940079593 drug Drugs 0.000 claims description 13
- PTNZGHXUZDHMIQ-UHFFFAOYSA-N 4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide;hydrochloride Chemical compound Cl.C1=CC=C2C(C)C(C(O)C3C(C(O)=C(C(N)=O)C(=O)C3N(C)C)(O)C3=O)C3=C(O)C2=C1O PTNZGHXUZDHMIQ-UHFFFAOYSA-N 0.000 claims description 7
- 230000002378 acidificating effect Effects 0.000 claims description 7
- 239000001569 carbon dioxide Substances 0.000 claims description 7
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 7
- 229960004082 doxycycline hydrochloride Drugs 0.000 claims description 7
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 5
- 238000005469 granulation Methods 0.000 claims description 4
- 230000003179 granulation Effects 0.000 claims description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims description 3
- 238000007908 dry granulation Methods 0.000 claims description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 3
- 229910000288 alkali metal carbonate Inorganic materials 0.000 claims description 2
- 150000008041 alkali metal carbonates Chemical class 0.000 claims description 2
- 229940072172 tetracycline antibiotic Drugs 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000003826 tablet Substances 0.000 description 26
- 210000003238 esophagus Anatomy 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- 239000002253 acid Substances 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 150000007524 organic acids Chemical class 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000007903 gelatin capsule Substances 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 2
- 239000007938 effervescent tablet Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 238000005550 wet granulation Methods 0.000 description 2
- XIYOPDCBBDCGOE-IWVLMIASSA-N (4s,4ar,5s,5ar,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methylidene-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C=C1C2=CC=CC(O)=C2C(O)=C2[C@@H]1[C@H](O)[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O XIYOPDCBBDCGOE-IWVLMIASSA-N 0.000 description 1
- SGKRLCUYIXIAHR-AKNGSSGZSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O SGKRLCUYIXIAHR-AKNGSSGZSA-N 0.000 description 1
- UVKFSMBPRQBNCH-UHFFFAOYSA-M 4,4-diphenylbutan-2-yl-ethyl-dimethylazanium;bromide Chemical compound [Br-].C=1C=CC=CC=1C(CC(C)[N+](C)(C)CC)C1=CC=CC=C1 UVKFSMBPRQBNCH-UHFFFAOYSA-M 0.000 description 1
- -1 Alkaline earth metal carbonates Chemical class 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 239000004099 Chlortetracycline Substances 0.000 description 1
- 102000016736 Cyclin Human genes 0.000 description 1
- 108050006400 Cyclin Proteins 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 239000004100 Oxytetracycline Substances 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- XMEVHPAGJVLHIG-FMZCEJRJSA-N chembl454950 Chemical compound [Cl-].C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H]([NH+](C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O XMEVHPAGJVLHIG-FMZCEJRJSA-N 0.000 description 1
- CYDMQBQPVICBEU-UHFFFAOYSA-N chlorotetracycline Natural products C1=CC(Cl)=C2C(O)(C)C3CC4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-UHFFFAOYSA-N 0.000 description 1
- 229960004475 chlortetracycline Drugs 0.000 description 1
- CYDMQBQPVICBEU-XRNKAMNCSA-N chlortetracycline Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-XRNKAMNCSA-N 0.000 description 1
- 235000019365 chlortetracycline Nutrition 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000254 damaging effect Effects 0.000 description 1
- 229960003722 doxycycline Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229940042016 methacycline Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229960000625 oxytetracycline Drugs 0.000 description 1
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 description 1
- 235000019366 oxytetracycline Nutrition 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 229960004989 tetracycline hydrochloride Drugs 0.000 description 1
- 150000003522 tetracyclines Chemical group 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI811677 | 1981-06-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO830210L true NO830210L (no) | 1983-01-24 |
Family
ID=8514443
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO830210A NO830210L (no) | 1981-06-01 | 1983-01-24 | Tabletter som ikke skader spiseroeret. |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0079928B1 (da) |
| JP (1) | JPS58500949A (da) |
| DD (1) | DD202503A5 (da) |
| DE (1) | DE3270579D1 (da) |
| DK (1) | DK158563C (da) |
| ES (1) | ES511731A0 (da) |
| FI (1) | FI83475C (da) |
| IT (1) | IT8221516A0 (da) |
| NO (1) | NO830210L (da) |
| PT (1) | PT74830B (da) |
| WO (1) | WO1982004191A1 (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4837030A (en) * | 1987-10-06 | 1989-06-06 | American Cyanamid Company | Novel controlled release formulations of tetracycline compounds |
| JP2523384B2 (ja) * | 1990-02-02 | 1996-08-07 | エスエス製薬株式会社 | 発泡性製剤組成物 |
| WO2005046651A1 (en) * | 2003-11-12 | 2005-05-26 | Ranbaxy Laboratories Limited | Liquid filled capsules of doxycycline |
| CN100340241C (zh) * | 2004-06-28 | 2007-10-03 | 中山大学中山眼科中心 | 一种滴眼液及其制备方法与用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1962015C3 (de) * | 1969-12-11 | 1980-07-03 | Uzina De Medicamente Bucuresti, Bukarest | Verfahren zur Herstellung von Tabletten mit raschem Zerfall |
| GB1380741A (en) * | 1971-02-05 | 1975-01-15 | Squibb & Sons Inc | Antibiotic compositions and their preparation |
| CA982478A (en) * | 1971-04-12 | 1976-01-27 | Jerome Berk | Orally administered drug composition for therapy in the treatment of narcotic drug addiction |
| GB1401360A (en) * | 1972-12-18 | 1975-07-16 | Biorex Laboratories Ltd | Pharmaceutical composition |
| GB1390683A (en) * | 1972-12-18 | 1975-04-16 | Biorex Laboratories Ltd | Pharmaceutical composition |
-
1982
- 1982-04-27 ES ES511731A patent/ES511731A0/es active Granted
- 1982-04-30 PT PT74830A patent/PT74830B/pt unknown
- 1982-05-27 IT IT8221516A patent/IT8221516A0/it unknown
- 1982-05-27 DD DD82240230A patent/DD202503A5/de unknown
- 1982-05-28 WO PCT/FI1982/000019 patent/WO1982004191A1/en not_active Ceased
- 1982-05-28 EP EP82901785A patent/EP0079928B1/en not_active Expired
- 1982-05-28 JP JP57501814A patent/JPS58500949A/ja active Pending
- 1982-05-28 DE DE8282901785T patent/DE3270579D1/de not_active Expired
-
1983
- 1983-01-14 DK DK013883A patent/DK158563C/da not_active IP Right Cessation
- 1983-01-24 NO NO830210A patent/NO830210L/no unknown
- 1983-01-31 FI FI830327A patent/FI83475C/fi not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK158563B (da) | 1990-06-11 |
| DK158563C (da) | 1990-11-12 |
| DK13883D0 (da) | 1983-01-14 |
| IT8221516A0 (it) | 1982-05-27 |
| ES8307096A1 (es) | 1983-07-01 |
| DK13883A (da) | 1983-01-14 |
| FI83475C (fi) | 1991-07-25 |
| EP0079928A1 (en) | 1983-06-01 |
| ES511731A0 (es) | 1983-07-01 |
| EP0079928B1 (en) | 1986-04-16 |
| FI83475B (fi) | 1991-04-15 |
| PT74830A (en) | 1982-05-01 |
| PT74830B (en) | 1983-11-30 |
| DD202503A5 (de) | 1983-09-21 |
| FI830327A0 (fi) | 1983-01-31 |
| WO1982004191A1 (en) | 1982-12-09 |
| FI830327L (fi) | 1983-01-31 |
| JPS58500949A (ja) | 1983-06-09 |
| DE3270579D1 (en) | 1986-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5132721B2 (ja) | ＨＭＧ−ＣｏＡ還元酵素阻害剤の徐放性改良製剤 | |
| AU618020B2 (en) | Covered retard forms | |
| CA2058946C (en) | Formulations for the oral administration of drugs with masked taste | |
| KR100254021B1 (ko) | 판토프라졸 함유 약제의 경구 투여 형태 | |
| RU2602911C2 (ru) | Фармацевтическая композиция, содержащая кальциевую соль розувастатина | |
| EP1219291A1 (en) | Texture masked particles containing an active ingredient | |
| HUT75158A (en) | Oral pharmaceutical compositions for selective release of drug in the colon, and process for producing them | |
| HUP0301465A2 (hu) | Gyorsan duzzadó készítmény gyomori retencióra és terápiás hatóanyagok szabályozott kioldódására, és a készítményt tartalmazó adagolási formák | |
| PT85213B (pt) | Processo para a preparacao de composicoes farmaceuticas de libertacao prolongada para administracao oral contendo um polimero celusosico | |
| JP2000516222A (ja) | 嚥下が容易な経口医薬組成物 | |
| CA2456976A1 (en) | Expandable gastric retention device | |
| US8999384B2 (en) | Immediate release compositions of acid labile drugs | |
| NO830210L (no) | Tabletter som ikke skader spiseroeret. | |
| JP2011520868A (ja) | 胃酸分泌を阻害するための組成物および方法 | |
| WO2005018618A1 (en) | Formulation of stable for moisture absorption and quickly dissolved tablet containing cefuroxime axetil and it's manufacturing process | |
| US5281421A (en) | Gemfibrozil formulations | |
| KR0171413B1 (ko) | 젬피브로질 제제 | |
| Kishorebabu et al. | A review on floating drug delivery system | |
| NO172834B (no) | Fremgangsmaate for fremstilling av tablett med overtrekk som inneholder poredannende substans | |
| Asif | Design and Characterization of Colon Targeted Nimesulide Double Coated Tablets for the Prophylaxis of Colon Cancer | |
| CA2044507A1 (en) | Gemfibrozil formulations | |
| Sreekanth | Formulation and Evaluation of Nizatiding Floatince Table. | |
| IE852069L (en) | Sustained release tablets | |
| AU2003245163A1 (en) | Extended-release tablets comprising divalproex sodium | |
| EP3398587A1 (en) | Compacted pharmaceutical preparation |